These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 10861434

  • 1. Changing incidence rate of invasive lobular breast carcinoma among older women.
    Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE.
    Cancer; 2000 Jun 01; 88(11):2561-9. PubMed ID: 10861434
    [Abstract] [Full Text] [Related]

  • 2. Regional variations in breast cancer incidence among California women, 1988-1997.
    Reynolds P, Hurley SE, Quach AT, Rosen H, Von Behren J, Hertz A, Smith D.
    Cancer Causes Control; 2005 Mar 01; 16(2):139-50. PubMed ID: 15868455
    [Abstract] [Full Text] [Related]

  • 3. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI, Daling JR, Malone KE.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 01; 14(4):1008-11. PubMed ID: 15824180
    [Abstract] [Full Text] [Related]

  • 4. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF, Chu KC, Chang S, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2004 Jul 01; 13(7):1128-35. PubMed ID: 15247123
    [Abstract] [Full Text] [Related]

  • 5. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI, Malone KE, Saltzman BS, Daling JR.
    Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564
    [Abstract] [Full Text] [Related]

  • 6. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ.
    Cancer; 2005 Jun 15; 103(12):2447-54. PubMed ID: 15887223
    [Abstract] [Full Text] [Related]

  • 7. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA, Krause EM, Lapaire O, Gueth U, Holzgreve W, Wight E.
    Arch Gynecol Obstet; 2008 Nov 15; 278(5):443-9. PubMed ID: 18335229
    [Abstract] [Full Text] [Related]

  • 8. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years.
    Li CI, Moe RE, Daling JR.
    Arch Intern Med; 2003 Oct 13; 163(18):2149-53. PubMed ID: 14557212
    [Abstract] [Full Text] [Related]

  • 9. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
    Saltzstein SL.
    Anat Pathol; 1996 Oct 13; 1():193-203. PubMed ID: 9390929
    [No Abstract] [Full Text] [Related]

  • 10. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
    Li CI, Anderson BO, Daling JR, Moe RE.
    JAMA; 2003 Mar 19; 289(11):1421-4. PubMed ID: 12636465
    [Abstract] [Full Text] [Related]

  • 11. Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast.
    Chikman B, Lavy R, Davidson T, Wassermann I, Sandbank J, Siegelmann-Danieli N, Halevy A.
    Isr Med Assoc J; 2010 Nov 19; 12(11):697-700. PubMed ID: 21243872
    [Abstract] [Full Text] [Related]

  • 12. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B, Amos A, Fletcher A, Kavanagh AM, Gertig DM.
    Cancer Epidemiol Biomarkers Prev; 2004 Oct 19; 13(10):1569-73. PubMed ID: 15466971
    [Abstract] [Full Text] [Related]

  • 13. Age-related lobular involution and risk of breast cancer.
    Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ, Goode EL, Visscher DW.
    J Natl Cancer Inst; 2006 Nov 15; 98(22):1600-7. PubMed ID: 17105983
    [Abstract] [Full Text] [Related]

  • 14. Detection method and breast carcinoma histology.
    Newcomer LM, Newcomb PA, Trentham-Dietz A, Storer BE, Yasui Y, Daling JR, Potter JD.
    Cancer; 2002 Aug 01; 95(3):470-7. PubMed ID: 12209738
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Geographic excess of estrogen receptor-positive breast cancer.
    Benz CC, Clarke CA, Moore DH.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 01; 12(12):1523-7. PubMed ID: 14693747
    [Abstract] [Full Text] [Related]

  • 20. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
    Kuo WH, Yen AM, Lee PH, Hou MF, Chen SC, Chen KM, Chen TH, Chang KJ.
    Breast Cancer Res Treat; 2006 Sep 01; 99(2):221-8. PubMed ID: 16544057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.